[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100657819":3},{"organization":4,"outcomesModule":7,"designInfo":25,"detailedDescription":11,"studyPopulation":11,"armGroups":34,"interventions":57,"overallOfficials":80,"centralContacts":84,"locations":93,"responsibleParty":347,"collaborators":11,"id":349,"slug":350,"hasResults":351,"nctId":352,"briefTitle":353,"officialTitle":354,"acronym":11,"eligibilityCriteria":355,"healthyVolunteers":356,"sex":357,"minAge":358,"maxAge":359,"enrollmentInfo":360,"targetDuration":11,"studyType":363,"phases":364,"briefSummary":366,"conditions":367,"keywords":11,"overallStatus":373,"whyStopped":11,"lastUpdateSubmitDate":374,"lastUpdatePostDateStruct":375,"startDateStruct":378,"completionDateStruct":380,"leadSponsor":382,"locationsCount":383},{"fullName":5,"class":6},"Eli Lilly and Company","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration",null,"Baseline up to 13 Weeks",[14,17,20,23],{"measure":15,"description":11,"timeFrame":16},"Pharmacokinetics (PK): Area Under the Plasma Concentration-Time Curve from Time Zero to Infinity (AUC0-∞) Following a Single Dose of LY4560736 in Healthy Participants","Baseline, Week 5",{"measure":18,"description":11,"timeFrame":19},"PK: Plasma LY4560736 Maximum Concentration at Steady State (Cmax,ss) in Participants with AD","Baseline through Week 13",{"measure":21,"description":11,"timeFrame":22},"Concentration of LY4560736 in Cerebrospinal Fluid (CSF) in Healthy Participants","Baseline through Study Completion (13 Weeks)",{"measure":24,"description":11,"timeFrame":22},"Change from Baseline of Amyloid Plaque levels as Assessed by Amyloid Positron Emission Tomography (PET) in Participants with AD",{"allocation":26,"interventionModel":27,"interventionModelDescription":11,"primaryPurpose":28,"observationalModel":11,"timePerspective":11,"maskingInfo":29},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":30,"maskingDescription":11,"whoMasked":31},"DOUBLE",[32,33],"PARTICIPANT","INVESTIGATOR",[35,41,47,53],{"label":36,"type":37,"description":38,"interventionNames":39},"LY4560736 Part A: Single-Ascending Dose (SAD)","EXPERIMENTAL","LY4560736 administered intravenously (IV) or subcutaneously (SC) in healthy volunteers.",[40],"Drug: LY4560736",{"label":42,"type":43,"description":44,"interventionNames":45},"Placebo Part A","PLACEBO_COMPARATOR","Placebo administered IV or SC in healthy volunteers.",[46],"Drug: Placebo",{"label":48,"type":37,"description":49,"interventionNames":50},"LY4560736 Part B: Multiple Ascending Dose (MAD)","LY4560736 administered IV to participants with AD. Florbetapir F 18 or Florbetaben F 18 will be administered IV during amyloid positron emission tomography (PET) scan.",[40,51,52],"Other: Florbetapir F18","Other: Florbetaben F 18",{"label":54,"type":43,"description":55,"interventionNames":56},"Placebo Part B","Placebo administered IV to participants with AD. Florbetapir F 18 or Florbetaben F 18 will be administered IV during amyloid PET scan.",[46,51,52],[58,63,66,70,73,77],{"type":59,"name":60,"description":61,"armGroupLabels":62,"otherNames":11},"DRUG","LY4560736","Administered intravenously (IV)",[36,48],{"type":59,"name":60,"description":64,"armGroupLabels":65,"otherNames":11},"Administered subcutaneously (SC)",[36],{"type":59,"name":67,"description":68,"armGroupLabels":69,"otherNames":11},"Placebo","Administered IV",[42,54],{"type":59,"name":67,"description":71,"armGroupLabels":72,"otherNames":11},"Administered SC",[42],{"type":74,"name":75,"description":68,"armGroupLabels":76,"otherNames":11},"OTHER","Florbetapir F18",[48,54],{"type":74,"name":78,"description":68,"armGroupLabels":79,"otherNames":11},"Florbetaben F 18",[48,54],[81],{"name":82,"affiliation":5,"role":83},"Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC\u002FGMT - 5 hours, EST)","STUDY_DIRECTOR",[85,90],{"name":86,"role":87,"phone":88,"phoneExt":11,"email":89},"Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or","CONTACT","1-317-615-4559","LillyTrials@Lilly.com",{"name":91,"role":87,"phone":11,"phoneExt":11,"email":92},"Physicians interested in becoming principal investigators please contact","clinical_inquiry_hub@lilly.com",[94,113,127,141,156,170,184,198,212,226,240,253,268,283,297,306,318,334],{"facility":95,"status":11,"city":96,"state":97,"zip":98,"country":99,"countryCode":100,"cosmosGeoPoint":101,"geoPoint":106,"contacts":107},"CenExel ACT","Anaheim","California","92801","United States","US",{"type":102,"coordinates":103},"Point",[104,105],-117.9145,33.83529,{"lat":105,"lon":104},[108,110],{"name":11,"role":87,"phone":109,"phoneExt":11,"email":11},"714-774-7777",{"name":111,"role":112,"phone":11,"phoneExt":11,"email":11},"Amina Haggag","PRINCIPAL_INVESTIGATOR",{"facility":114,"status":11,"city":115,"state":97,"zip":116,"country":99,"countryCode":100,"cosmosGeoPoint":117,"geoPoint":121,"contacts":122},"Irvine Clinical Research","Irvine","92614",{"type":102,"coordinates":118},[119,120],-117.82311,33.66946,{"lat":120,"lon":119},[123,125],{"name":11,"role":87,"phone":124,"phoneExt":11,"email":11},"949-753-1663",{"name":126,"role":112,"phone":11,"phoneExt":11,"email":11},"Elly Lee",{"facility":128,"status":11,"city":129,"state":97,"zip":130,"country":99,"countryCode":100,"cosmosGeoPoint":131,"geoPoint":135,"contacts":136},"Collaborative Neuroscience Network - CNS","Los Alamitos","90720",{"type":102,"coordinates":132},[133,134],-118.07256,33.80307,{"lat":134,"lon":133},[137,139],{"name":11,"role":87,"phone":138,"phoneExt":11,"email":11},"714-799-7799",{"name":140,"role":112,"phone":11,"phoneExt":11,"email":11},"Steven Reynolds",{"facility":142,"status":11,"city":143,"state":144,"zip":145,"country":99,"countryCode":100,"cosmosGeoPoint":146,"geoPoint":150,"contacts":151},"Fortrea Clinical Research Unit","Daytona Beach","Florida","32117",{"type":102,"coordinates":147},[148,149],-81.02283,29.21081,{"lat":149,"lon":148},[152,154],{"name":11,"role":87,"phone":153,"phoneExt":11,"email":11},"386-366-6400",{"name":155,"role":112,"phone":11,"phoneExt":11,"email":11},"Chiamaka Iheme",{"facility":157,"status":11,"city":158,"state":144,"zip":159,"country":99,"countryCode":100,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"K2 Medical Research - The Villages","Lady Lake","32159",{"type":102,"coordinates":161},[162,163],-81.92286,28.91749,{"lat":163,"lon":162},[166,168],{"name":11,"role":87,"phone":167,"phoneExt":11,"email":11},"321-278-5590",{"name":169,"role":112,"phone":11,"phoneExt":11,"email":11},"Craig Curtis",{"facility":171,"status":11,"city":172,"state":144,"zip":173,"country":99,"countryCode":100,"cosmosGeoPoint":174,"geoPoint":178,"contacts":179},"K2 Medical Research","Maitland","32751",{"type":102,"coordinates":175},[176,177],-81.36312,28.62778,{"lat":177,"lon":176},[180,182],{"name":11,"role":87,"phone":181,"phoneExt":11,"email":11},"407-232-9262",{"name":183,"role":112,"phone":11,"phoneExt":11,"email":11},"Brandon Lenox",{"facility":185,"status":11,"city":186,"state":144,"zip":187,"country":99,"countryCode":100,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"Charter Research","Orlando","32803",{"type":102,"coordinates":189},[190,191],-81.37924,28.53834,{"lat":191,"lon":190},[194,196],{"name":11,"role":87,"phone":195,"phoneExt":11,"email":11},"407-337-1000",{"name":197,"role":112,"phone":11,"phoneExt":11,"email":11},"Diana Balsalobre",{"facility":199,"status":11,"city":200,"state":144,"zip":201,"country":99,"countryCode":100,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"Progressive Medical Research","Port Orange","32127",{"type":102,"coordinates":203},[204,205],-80.99561,29.13832,{"lat":205,"lon":204},[208,210],{"name":11,"role":87,"phone":209,"phoneExt":11,"email":11},"386-304-7070",{"name":211,"role":112,"phone":11,"phoneExt":11,"email":11},"Alexander White",{"facility":213,"status":11,"city":214,"state":144,"zip":215,"country":99,"countryCode":100,"cosmosGeoPoint":216,"geoPoint":220,"contacts":221},"Alzheimer's Research and Treatment Center","Stuart","34996",{"type":102,"coordinates":217},[218,219],-80.25283,27.19755,{"lat":219,"lon":218},[222,224],{"name":11,"role":87,"phone":223,"phoneExt":11,"email":11},"772-675-0000",{"name":225,"role":112,"phone":11,"phoneExt":11,"email":11},"Adam Falchook",{"facility":227,"status":11,"city":228,"state":144,"zip":229,"country":99,"countryCode":100,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"K2 Medical Research - Tampa","Tampa","33634",{"type":102,"coordinates":231},[232,233],-82.45843,27.94752,{"lat":233,"lon":232},[236,238],{"name":11,"role":87,"phone":237,"phoneExt":11,"email":11},"813-800-5252",{"name":239,"role":112,"phone":11,"phoneExt":11,"email":11},"Kelley Wilson",{"facility":185,"status":11,"city":241,"state":144,"zip":242,"country":99,"countryCode":100,"cosmosGeoPoint":243,"geoPoint":247,"contacts":248},"The Villages","32162-2698",{"type":102,"coordinates":244},[245,246],-81.95994,28.93408,{"lat":246,"lon":245},[249,251],{"name":11,"role":87,"phone":250,"phoneExt":11,"email":11},"352-775-1000",{"name":252,"role":112,"phone":11,"phoneExt":11,"email":11},"Jeffrey Norton",{"facility":254,"status":11,"city":255,"state":256,"zip":257,"country":99,"countryCode":100,"cosmosGeoPoint":258,"geoPoint":262,"contacts":263},"Accel Research Sites - NeuroStudies Clinical Research Unit","Decatur","Georgia","30030",{"type":102,"coordinates":259},[260,261],-84.29631,33.77483,{"lat":261,"lon":260},[264,266],{"name":11,"role":87,"phone":265,"phoneExt":11,"email":11},"404-475-0552",{"name":267,"role":112,"phone":11,"phoneExt":11,"email":11},"Marshall Nash",{"facility":269,"status":11,"city":270,"state":271,"zip":272,"country":99,"countryCode":100,"cosmosGeoPoint":273,"geoPoint":277,"contacts":278},"QUEST Research Institute","Farmington Hills","Michigan","48334",{"type":102,"coordinates":274},[275,276],-83.37716,42.48531,{"lat":276,"lon":275},[279,281],{"name":11,"role":87,"phone":280,"phoneExt":11,"email":11},"248-957-8940",{"name":282,"role":112,"phone":11,"phoneExt":11,"email":11},"Aaron Ellenbogen",{"facility":284,"status":11,"city":285,"state":11,"zip":286,"country":287,"countryCode":288,"cosmosGeoPoint":289,"geoPoint":293,"contacts":294},"Xuanwu Hospital Capital Medical University","Beijing","100053","China","CN",{"type":102,"coordinates":290},[291,292],116.39723,39.9075,{"lat":292,"lon":291},[295],{"name":296,"role":112,"phone":11,"phoneExt":11,"email":11},"Cuibai Wei",{"facility":298,"status":11,"city":299,"state":11,"zip":300,"country":287,"countryCode":288,"cosmosGeoPoint":11,"geoPoint":11,"contacts":301},"Huashan Hospital, Fudan University","Minhang District","201107",[302,304],{"name":11,"role":87,"phone":303,"phoneExt":11,"email":11},"021-54601999",{"name":305,"role":112,"phone":11,"phoneExt":11,"email":11},"Jintai Yu",{"facility":307,"status":11,"city":308,"state":11,"zip":309,"country":287,"countryCode":288,"cosmosGeoPoint":310,"geoPoint":314,"contacts":315},"Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","Shanghai","200127",{"type":102,"coordinates":311},[312,313],121.45806,31.22222,{"lat":313,"lon":312},[316],{"name":317,"role":112,"phone":11,"phoneExt":11,"email":11},"Gang Wang",{"facility":319,"status":11,"city":320,"state":11,"zip":321,"country":322,"countryCode":323,"cosmosGeoPoint":324,"geoPoint":328,"contacts":329},"The University of Tokyo Hospital","Bunkyō City","113-8655","Japan","JP",{"type":102,"coordinates":325},[326,327],139.4217,35.5331,{"lat":327,"lon":326},[330,332],{"name":11,"role":87,"phone":331,"phoneExt":11,"email":11},"81120023812",{"name":333,"role":112,"phone":11,"phoneExt":11,"email":11},"Yoshiki Niimi",{"facility":335,"status":11,"city":336,"state":11,"zip":337,"country":322,"countryCode":323,"cosmosGeoPoint":338,"geoPoint":342,"contacts":343},"National Center for Geriatrics and Gerontology","Ōbu","4748511",{"type":102,"coordinates":339},[340,341],136.94947,35.01756,{"lat":341,"lon":340},[344,345],{"name":11,"role":87,"phone":331,"phoneExt":11,"email":11},{"name":346,"role":112,"phone":11,"phoneExt":11,"email":11},"Keisuke Suzuki",{"type":348,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100657819","phase-1-a-study-of-ly4560736-in-healthy-participants-and-participants-with-alzheimers-disease-ad-100657819",false,"NCT07843459","A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)","A Placebo-Controlled, Single- and Multiple-Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease","Inclusion Criteria:\n\n* Participants must meet eligibility criteria in the A1D-MC-ATMP screening protocol before entry into the treatment study.\n* To qualify as a participant of first-generation Japanese origin, the participant, the participant's biological parents, and all the participant's biological grandparents must be of exclusive Japanese descent and born in Japan.\n* To qualify as Chinese for this study, all four of the participant's biological grandparents must be of exclusive Chinese descent and born in China.\n\nExclusion Criteria:\n\n* Have a condition that predisposes the participant to an infection.\n* Have a current or recent acute, active infection.\n* Have active tuberculosis (TB), have or have had latent TB.\n* Are receiving therapeutic antibodies or expected to initiate treatment with therapeutic antibodies during the study.",true,"ALL","18 Years","85 Years",{"count":361,"type":362},111,"ESTIMATED","INTERVENTIONAL",[365],"PHASE1","The purpose of this study is to see how safe LY4560736 is and to see how much and how quickly LY4560736 gets into the bloodstream. For healthy participants, the study also looks at how much LY4560736 gets into the brain. This part of the study lasts up to 13 weeks which includes staying in the Clinical Research Unit (CRU) for at least 4 days. This group will include Japanese participants, and the Sponsor may choose to enroll Chinese participants. For participants with Alzheimer's Disease, the study will also look at levels of a specific Alzheimer's-related protein in the brain and will last up to 13 weeks which includes staying in the CRU twice, each lasts about 1 to 2 days. Japanese participants, and potentially Chinese participants, may also be enrolled in this group.",[368,369,370,371,372],"Healthy Volunteers","Alzheimer Disease","Amyloid","Plaque, Amyloid","Plasma","NOT_YET_RECRUITING","2026-10-07",{"date":376,"type":377},"2026-10-08","ACTUAL",{"date":379,"type":362},"2026-10",{"date":381,"type":362},"2028-07",{"name":5,"class":6},18]